wet-AMD

Ocular Therapeutix joins the long-acting race
EP Vantage
Wed, 09/28/22 - 10:40 am
Ocular Therapeutix
wet-AMD
wet age-related macular degeneration
OTX-TKI
Regeneron's Eylea could lose 30% of its patients to Roche's Vabysmo over the next year: analyst survey
Fierce Pharma
Mon, 06/13/22 - 09:46 pm
Regeneron
Eylea
Vabysmo
Roche
wet-AMD
What happened a year ago this week in biopharma? August 12-18, 2018
Mon, 08/19/19 - 11:04 am
Regeneron
Novartis
wet-AMD
Eylea
ethics
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
SCLC
What happened a year ago this week in biopharma? August 12-18, 2018
CP WIre
Sun, 08/18/19 - 04:30 pm
Regeneron
Novartis
wet-AMD
Eylea
ethics
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
SCLC
Roche expands its PhIII program for Eylea rival as long-acting data back its blockbuster contender faricimab
Endpoints
Mon, 10/29/18 - 10:27 am
Roche
Genentech
Regeneron
Novartis
Eylea
faricimab
wet-AMD
Opthea touts data from wet-AMD trial
Drug Delivery Business News
Tue, 08/15/17 - 10:01 am
Opthea
clnical trials
wet-AMD
OPT-302
anti-VEGF
Lpath to cut jobs as eye drug fails mid-stage study
Yahoo/Reuters
Wed, 05/20/15 - 09:53 am
Lpath
layoffs
iSONEP
wet-AMD
Ophthotech deal with Novartis leaves Fovista well-positioned, says Stifel
The Fly on the Wall
Tue, 05/20/14 - 11:24 am
Ophthotech
Fovista
Novartis
wet age-related macular degeneration
wet-AMD
Ohr Pharma: A Pure 2014 Catalyst Play With Large Potential
Seeking Alpha
Tue, 11/12/13 - 01:08 pm
Ohr Pharmaceutical
wet-AMD
Squalamine Eye Drops
ovarian cancer
Lpath Restarts NEXUS Trial; Breathes New Life Into Shares
Seeking Alpha
Wed, 10/10/12 - 11:42 am
Lpath
iSONEP
wet-AMD
Lpath Begins iSONEP Dosing in Nexus Phase 2 Study
Yahoo
Wed, 10/3/12 - 11:21 am
Lpath
iSONEP
wet-AMD
monoclonal antibodies
Regeneron drops 6% after Ophthotech reports positive data
The Fly on the Wall
Wed, 06/13/12 - 12:01 pm
Ophthotech
Regeneron
Roche
Lucentis
Fovista
Eylea
wet-AMD
Regeneron Drops as Eye Drug Shown Similar to Roche's Lucentis
Bloomberg Businessweek
Mon, 12/5/11 - 12:28 pm
Roche
Lucentis
Regeneron
Eyela
wet-AMD
Regeneron Soars on Eye-Drug Rival Setback
TheStreet.com
Wed, 09/21/11 - 11:24 pm
Regeneron
Roche
Avastin
wet-AMD
age-related macular degeneration
QLT Announces Toronto Stock Exchange Approval of Increased Share Repurchase Program
Yahoo/Globe NewsWire
Sat, 05/22/10 - 09:45 am
QLT
Visudyne
wet-AMD
Lpath's iSONEP Is Well Tolerated at All Dose Levels in a Phase 1 Trial in Wet-AMD Patients
Yahoo/MarketWire
Thu, 10/8/09 - 11:04 am
Lpath
iSONEP
wet-AMD